Healio

XEN1101 significantly reduced monthly seizures for adults with focal-onset epilepsy

Please provide your email address to receive an email when new articles are posted on . XEN1101 is a novel small-molecule selective Kv7.2/Kv7.3 potassium channel opener. A 25 mg dose of XEN1101 ...
Nasdaq

CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures The CORE-VNS 36-month data analysis reaffirms the effectiveness of VNS Therapy ...

Ovid reports positive Phase I data for epilepsy therapy OV329

The study assessed OV329 in 68 healthy subjects, comprising 51 individuals receiving active treatment and 17 receiving placebo.
Healio

FDA approves Xcopri for oral suspension, nasogastric tube administration

Please provide your email address to receive an email when new articles are posted on . The FDA approved two new delivery methods of Xcopri for adults with partial-onset seizures, with the drug able ...
WebMD

Managing Partial-Onset Seizures with Fycompa

Seizures can affect your daily life and well-being. Certain medicines can help lower the risk of having seizures, which can help manage your condition. Fycompa is a medicine used to manage ...

Pain and antidepressant drug combo linked to increased seizure risk in older adults

When older adults living in nursing homes are prescribed the pain medicine tramadol alongside certain antidepressants, their risk of seizures may go up, according to a study published in Neurology.